Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Item 9 Labs (INLB) Receivables - Other (2021 - 2023)

Item 9 Labs' Receivables - Other history spans 4 years, with the latest figure at $4.8 million for Q2 2023.

  • For Q2 2023, Receivables - Other fell 44.28% year-over-year to $4.8 million; the TTM value through Jun 2023 reached $4.8 million, down 44.28%, while the annual FY2022 figure was $7.7 million, 56.51% down from the prior year.
  • Receivables - Other reached $4.8 million in Q2 2023 per INLB's latest filing, roughly flat from $4.8 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $17.7 million in Q3 2021 to a low of $4.8 million in Q1 2023.
  • Average Receivables - Other over 3 years is $9.3 million, with a median of $8.2 million recorded in 2022.
  • The largest YoY upside for Receivables - Other was 39.87% in 2022 against a maximum downside of 56.51% in 2022.
  • A 3-year view of Receivables - Other shows it stood at $12.8 million in 2021, then tumbled by 39.87% to $7.7 million in 2022, then plummeted by 38.0% to $4.8 million in 2023.
  • Per Business Quant, the three most recent readings for INLB's Receivables - Other are $4.8 million (Q2 2023), $4.8 million (Q1 2023), and $7.7 million (Q4 2022).